Please login to the form below

Not currently logged in

Santen Pharmaceutical

This page shows the latest Santen Pharmaceutical news and features for those working in and with pharma, biotech and healthcare.

NICE no for new eye disease drug

NICE no for new eye disease drug

NICE's preliminary recommendation has been to ask Santen Pharmaceutical for more information on Ikervis (ciclosporin) for treating severe keratitis in adults with dry eye disease which has not improved despite

Latest news

  • Meeting with resistance

    Several pharmaceutical companies appear to have recently found ways of overcoming the manufacturing obstacles. ... Low-grade B-cell lymphoma; mantle cell lymphoma. Japan. Diquafosol. Diquas Ophthalmic Solution 3% (Santen Pharmaceutical).

  • Thin on the ground

    UK. Dorzolamide/timolol. Cosopt (Santen Pharmaceutical Co). Glaucoma and ocular hypertension. Japan. ... Fera Pharmaceuticals. High intraocular pressure. US. Omeprazole/sodium bicarbonate. Par Pharmaceutical Companies.

  • News in Brief, May 30, 2007

    They also did not dismiss a combination of two of the pharmaceutical industry's biggest companies. ... Japan. He has over 30 years experience within the pharmaceutical industry. Currently, Muramatsu is a non-executive director of Santen Pharmaceutical

More from news
Approximately 1 fully matching, plus 3 partially matching documents found.

Latest Intelligence

  • Deal Watch table for March 2014 Deal Watch table for March 2014

    265.3. Takeda Pharmaceutical/ Otsuka Pharmaceutical. Co-promotion. TAK-438 (vonoprazan fumarate) for acid-related diseases (NDA filed JP). ... 22. Tracon Pharmaceuticals/ Santen Pharmaceutical Co. Licence. Tracon's anti‐endoglin antibodies, including

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

  • Luis Iglesias heads Santen EMEA Luis Iglesias heads Santen EMEA

    president and chief operating office of parent company Santen Pharmaceutical. ... Iglesias initially joined Santen in 2017 as its senior vice president, commercial EMEA and brought with him more than 25 years’ experience in pharmaceuticals in Europe

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs


Add my company
OPEN Health

OPEN Health is a family of expert practices, working in partnership to drive positive change in healthcare communications & market...

Latest intelligence

Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...
The heavy toll of COVID-19 on cancer patients
We all know that finding and treating cancer early saves lives. During the COVID-19 pandemic, oncology treatments paused while cancer continued to spread. So, what has been the impact of...